Solace Therapeutics capped a big week with a win at the MassMEDIC 11th Annual Medtech Investors Conference, landing the first MedTech Ignite 10k Innovative Technology Competition award.
The Framingham, Mass.-based medical device maker won CE Mark approval in the European Union Oct. 1 for its intravesical system to treat female stress urinary incontinence.
The device is a small, quarter-sized balloon that floats inside the bladder. Inserted via catheter during an out-patient procedure, the balloon is designed to relieve the pressure fluctuations within the bladder that lead to incontinence.
The award was presented at the conference at UMass-Boston. MassMEDIC’s Medtech IGNITE program is aimed at fostering the growth of early-stage startup medical device firms.